Viscogliosi Brothers Acquisition Corp.
Status: Liquidated
U=S+W/2
W=S@11.5
IPO Proceeds, $M | $86.25M |
---|---|
IPO Date | Jan 7, 2022 |
CEO | John J. Viscogliosi |
Left Lead | Raymond James |
IPO Cash in Trust | 102.0% |
SPAC Tenor | 18 months |
IPO Sector |
Healthcare
The neuro-musculoskeletal industry in North America and Europe |
IPO Geography | Global |
Target Company | N/A |
Deal Announced | N/A |
Deal Size, $M | TBD |
Deal Sector | TBD |
Deal Geography | TBD |
SEC Filings | www.sec.gov |
Approval Vote | TBD |
Amendment Vote | TBD |
Closing Date | Jul 11, 2023 |
VBOC
VBOCU
VBOCW
Price | |
---|---|
Volume, 3-month avg. | N/A |
Sign up for Free Trial
No credit card required
Sign in for more on Viscogliosi Brothers Acquisition Corp.:
- Structure and cap table
- 7 directors & officers
- 13 filings and events
- 1 underwriters
Structure
Sign in to view structure, cap table, and calendar of events.
Team
Name | Age | Title |
---|---|---|
John J. Viscogliosi | 53 | Chief Executive Officer, President and Chairman |
F. Samuel Eberts III | 62 | Director |
Dan Drawbaugh | 62 | Director |
John N. Kastanis | 72 | Director |
Marc R. Viscogliosi | 46 | Director |
Jack E. Zigler | 68 | Director |
Fares Zahir | Director |
Sign in to view team biographies and more sponsor and affiliate data.
Advisors
Underwriters
Raymond James | BR | 7,500,000 | units |
7,500,000 | units | ||
Up-Front UW fee | 2.00 | % | |
Deferred UW fee |
2.00 | % |
Sign in to view more advisor data.